BridgeBio Pharma Inc (BBIO)
28.53
+0.76
(+2.74%)
USD |
NASDAQ |
Dec 24, 16:00
BridgeBio Pharma Cash from Investing (Quarterly): 38.23M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -2.057B |
| Alnylam Pharmaceuticals Inc | -30.25M |
| Cassava Sciences Inc | -0.017M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Vertex Pharmaceuticals Inc | -348.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -180.57M |
| Cash from Financing (Quarterly) | 0.707M |
| Free Cash Flow | -456.32M |
| Free Cash Flow Per Share (Quarterly) | -0.967 |
| Free Cash Flow to Equity (Quarterly) | -184.02M |
| Free Cash Flow Yield | -8.77% |